← Leaderboards
Josephine M Egan
Johns Hopkins University
$65,169
Attributed
$65,169
Total exposure
4
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$65,169 · 4
By mechanism
M01$65,169 · 4
Top collaborators
No co-investigators on record.
Most similar at Johns Hopkins University
Same institution · by research overlap
- Elizabeth Selvin$25,163,675
- Lori Chaffin Jordan$8,910,492
- Sherita Hill Golden$8,542,652
- Samuel R Denmeade$5,431,317
- Peter G Vekilov$2,776,224
Others in their field
Top investigators on “Noninsulin Dependent Diabetes Mellitus”
- Kathryn Hirst · Caritas St. Elizabeth'S Medical Center$69,532,406
- Katherine M Detre · University Of Pittsburgh At Pittsburgh$33,288,043
- Mark Andrew Espeland · Wake Forest University Health Sciences$18,466,667
- C Ronald Kahn · Joslin Diabetes Center$17,946,199
- F. Xavier Pi-Sunyer · Columbia University Health Sciences$13,600,448
- David M Nathan · Massachusetts Institute Of Technology$13,352,064
Research focus
Noninsulin Dependent Diabetes MellitusHuman SubjectGlucose MetabolismInsulinBlood GlucoseClinical ResearchInsulin Sensitivity /ResistanceDiabetes Mellitus TherapyHuman Therapy EvaluationGlucose Clamp TechniqueHormone Regulation /Control MechanismIncretin HormoneHypoglycemic AgentsPancreasDrug Administration RoutesPancreatic Islet FunctionAgingExenatideGastrointestinal HormonesDiabetes MellitusLiver MetabolismObesityGlucagon-Like Peptide 1Patient Oriented Research
Grant awards (43)
Drug Development of GLP-1 receptor agonists$444,457
Z01 · FY2008 · AG · contact PI
Aging And The Pancreas$172,341
Z01 · FY2008 · AG · contact PI
Effects Of Androgen Deficiency on Glucose Homeostasis$36,282
Z01 · FY2008 · AG · contact PI
Drug Development of GLP-1 receptor agonists$1,079,455
Z01 · FY2007 · AG · contact PI
Aging And The Pancreas$521,116
Z01 · FY2007 · AG · contact PI
Effects Of Androgen Deficiency on Glucose Homeostasis$37,223
Z01 · FY2007 · AG · contact PI
Aging And The Pancreas$0
Z01 · FY2006 · AG · contact PI
Effects Of GLP-1 On Glucose Homeostasis$0
Z01 · FY2006 · AG · contact PI
Drug Development of GLP-1 receptor agonists$0
Z01 · FY2006 · AG · contact PI
Drug Development of GLP-1 receptor agonists$0
Z01 · FY2005 · AG
Effects Of Glp-1 On Glucose Homeostasis$0
Z01 · FY2005 · AG
Aging And The Pancreas$0
Z01 · FY2005 · AG
Aging And The Pancreas$0
Z01 · FY2004 · AG
Effects Of Glp-1 On Glucose Homeostasis$0
Z01 · FY2004 · AG
Drug Development of GLP-1 receptor agonists$0
Z01 · FY2004 · AG
Drug Development of GLP-1 receptor agonists$0
Z01 · FY2003 · AG
Exendin-4 Is A Treatment For Type 2 Diabetes$0
Z01 · FY2003 · AG
Effects Of Glp-1 On Glucose Homeostasis$0
Z01 · FY2003 · AG
Aging And The Pancreas$0
Z01 · FY2003 · AG
Drug Development of GLP-1 receptor agonists$0
Z01 · FY2002 · AG
GLP-1 EFFECTS ON INSULIN SECRETION AND SENSITIVITY IN TYPE II DIABETES$0
M01 · FY2002 · RR
EFFECT OF GLP 1 ON GLUCOSE UPTAKE &HEPATIC GLUCOSE OUTPUT IN OBESITY$0
M01 · FY2002 · RR
Aging And The Pancreas$0
Z01 · FY2002 · AG
Effects Of Glp-1 On Glucose Homeostasis$0
Z01 · FY2002 · AG
Exendin-4 Is A Treatment For Type 2 Diabetes$0
Z01 · FY2002 · AG
EFFECT OF GLP 1 ON GLUCOSE UPTAKE &HEPATIC GLUCOSE OUTPUT IN OBESITY$0
M01 · FY2001 · RR
GLP-1 EFFECTS ON INSULIN SECRETION AND SENSITIVITY IN TYPE II DIABETES$0
M01 · FY2001 · RR
Exendin 4 Is A Treatment For Type 2 Diabetes$0
Z01 · FY2001 · AG
Effects Of Glp1 On Glucose Homeostasis$0
Z01 · FY2001 · AG
Exendin 4 As A Treatment For Diabetes Mellitus$0
Z01 · FY2001 · AG
Aging And The Pancreas$0
Z01 · FY2001 · AG
GLP-1 EFFECTS ON INSULIN SECRETION AND SENSITIVITY IN TYPE II DIABETES$65,169
M01 · FY2000 · RR
EXENDIN-4 ON INSULIN RESISTANCE AND GLUCOSE UPTAKE$0
M01 · FY2000 · RR
EXENDIN-4 ON INSULIN RESISTANCE AND GLUCOSE UPTAKE$0
M01 · FY2000 · RR
GLP 1 ON GLUCOSE UPTAKE AND GLUCOSE OUTPUT IN OBESITY$0
M01 · FY2000 · RR
GLP 1 ON GLUCOSE UPTAKE AND GLUCOSE OUTPUT IN OBESITY$0
M01 · FY2000 · RR
GLP 1 ON GLUCOSE UPTAKE AND GLUCOSE OUTPUT IN OBESITY$0
M01 · FY2000 · RR
Exendin-4 is a treatment for Type 2 Diabetes$0
Z01 · FY2000 · AG
Acute effects of GLP-1 on glucose uptake in obese subjects$0
Z01 · FY2000 · AG
EXENDIN-4 AS A TREATMENT FOR DIABETES MELLITUS$0
Z01 · FY2000 · AG
AGING AND THE PANCREAS$0
Z01 · FY2000 · AG
EXENDIN-4 IN INSULIN SECRETION AND SENSITIVITY IN DIABETES$0
M01 · FY2000 · RR
EXENDIN-4 IN INSULIN SECRETION AND SENSITIVITY IN DIABETES$0
M01 · FY2000 · RR